Newsbenzinga
Full Transcript: Xeris Biopharma Holdings Q2 2026 Earnings Call
· Published
Article summary
Xeris Biopharma Holdings (NASDAQ:XERS) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive
An excerpt from the original article.
Comments —
Loading comments…